The Evexia Lifecare share price climbed 3.44% to ₹1.80 on November 17, marking the second consecutive session of gains. This surge comes amid heightened trading activity, reflecting renewed market interest in the penny stock.
Market Performance
Evexia Lifecare, a small-cap healthcare company, has faced a challenging year, with its share price under pressure for months:
- Down 13% in the past month
- Declined 24% over the last three months
- Fell 36% in six months
- Plunged 50% on a YTD basis
Despite this overall downtrend, the stock saw renewed momentum on November 17, supported by heavier trading volumes. Around 20 lakh shares changed hands on the BSE, exceeding the one-week average of 17 lakh shares.
Q2 FY26 Financial Highlights
Evexia Lifecare recently released its second-quarter results, showing mixed performance in revenue and profits:
- Consolidated net profit: ₹37.19 lakh, down from ₹93.80 lakh in Q2 FY25
- Revenue from operations: ₹25.72 crore, slightly lower than ₹26.70 crore in the same quarter last year
- Previous quarter revenue: ₹22.09 crore (Q1 FY26)
- Previous quarter net profit: ₹63.48 lakh
While profits have declined YoY, the company continues to maintain a steady revenue base, driven primarily by its pharmaceutical chemicals trading business, which forms the bulk of its income.
Company Overview
Evexia Lifecare operates in multiple segments of the healthcare industry:
- Pharmaceutical chemicals trading: Key revenue contributor; chemicals used in drug manufacturing.
- Retail pharmacy services: Expanding reach through physical outlets
- Diagnostic solutions: Offering testing services and clinical support
- Personal healthcare products: Complementing pharma and retail operations
The company’s diversified portfolio provides a buffer against sector volatility, though small-cap and penny stock dynamics have kept the share price under pressure in the past year.
Share Price Trend
Evexia Lifecare’s share price has experienced significant fluctuations over time:
- One-year decline: 56%
- Three-year gain: 7%
- Recent surge: 3.44% on November 17
The recent uptick indicates temporary momentum in the penny stock segment under ₹2, attracting traders seeking small-cap opportunities.
Summary
Evexia Lifecare’s Q2 FY26 performance highlights:
- Net profit: ₹37.19 lakh, down YoY
- Revenue: ₹25.72 crore, slightly lower than last year
- Heavier trading volumes: 20 lakh shares on BSE
- Diversified operations: Pharma chemicals, retail pharmacies, diagnostics, and healthcare products
Despite the challenging performance over the past year, the company continues to operate in a niche healthcare segment with a diversified portfolio. The recent price movement shows renewed market activity, making Evexia Lifecare shares a focus in small-cap penny stocks under ₹2.
Easy & quick
Leave A Comment?